8-K 1 dfc063006

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________

FORM 8-K


CURRENT REPORT


PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934


DATE OF REPORT (Date of earliest event reported): May 22, 2012


IGI LABORATORIES, INC.

(Exact name of registrant as specified in charter)


DELAWARE

001-08568

01-0355758

(State or Other Jurisdiction of
Incorporation)

(Commission
file number)

(I.R.S. Employer
Identification
Number)


105 Lincoln Avenue

Buena, New Jersey 08310

(Address of principal executive offices)(Zip Code)


(856) 697-1441

(Registrant’s telephone number, including area code)


Not Applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

[  ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

[  ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))

 

 

[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))





Item 5.07. Submission of Matters to a Vote of Security Holders.


On May 22, 2012, the Company held its Annual Meeting of Stockholders. At the Annual Meeting, 35,888,534 votes were present in person or by proxy, which represented 84.5% of the total outstanding eligible votes as of the record date of April 25, 2012. Two proposals were before the meeting: (1) the election of six directors to serve until the next Annual Meeting of Stockholders and until their respective successors have been elected and qualified and (2) the ratification of the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2012.


Both of the proposals were approved. The votes with respect to the proposals are set forth below.


(1)

Elect six directors to serve until the next Annual Meeting of Stockholders:


Name of Director
Nominees


Votes For


Votes Withheld

 

 

 

James C. Gale

17,104,880

121,689

 

 

 

Narendra N. Borkar

17,116,780

109,789

 

 

 

Michael Hemric

17,104,215

122,354

 

 

 

Charles Moore

17,033,580

192,989

 

 

 

Joyce Erony

17,073,882

152,687

 

 

 

Bhaskar Chaudhuri

17,099,165

127,404


(2)

Ratify the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2012:


Votes For

Votes Against

Votes Abstain

 

 

 

35,539,267

65,167

4,107





SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

IGI LABORATORIES, INC.

 

 

Date: May 25, 2012

By: /s/Jenniffer Collins

 

Name: Jenniffer Collins

 

Title: Chief Financial Officer